Abstract:We have previously shown that double-stranded RNA-triggered, Toll-like receptor 3 (TLR3)-mediated signaling is independent of MyD88, IRAK4, and IRAK. Instead, TRAF6, TAK1, and TAB2 are recruited to TLR3 on poly(I·C) stimulation. TRAF6-TAK1-TAB2 are then translocated to the cytosol where TAK1 is phosphorylated and activated, leading to the activation of IκB kinase and NFκB. The present study addressed two important questions: ( i ) How are TRAF6, TAK1, and TAB2 recruited to TLR3? ( ii ) Are TRAF6, TAK1, and TAB2 also required for TLR3-mediated IRF3 activation? Recently, a novel Toll-IL-1 receptor (TIR)-containing adapter, TIR domain-containing adapter inducing IFN-β (TRIF), was shown to play a critical role in TLR3-mediated activation of NF-κB and IRF3. We found that TLR3 recruits TRAF6 via adapter TRIF through a TRAF6-binding sequence in TRIF (PEEMSW, amino acids 250-255). Mutation of this TRAF6-binding sequence abolished the interaction of TRIF with TRAF6, but not with TLR3. Interestingly, mutation of the TRAF6-binding site of TRIF only abolished its ability to activate NF-κB but not IRF3, suggesting that TLR3-mediated activation of NF-κB and IRF3 might bifurcate at TRIF. In support of this finding, we showed that DN-TRAF6 and DN-TAK1 blocked poly(I·C)-induced NF-κB but not IRF3 activation. Furthermore, whereas poly(I·C)-induced NF-κB activation is completely abolished inTRAF6-/- MEFs, the signal-induced activation of IRF3 is TRAF6 independent. In conclusion, TRIF recruits TRAF6-TAK1-TAB2 to TLR3 through its TRAF6-binding site, which is required for NF-κB but not IRF3 activation. Therefore, double-stranded RNA-induced TLR3/TRIF-mediated NF-κB and IRF3 activation diverge at TRIF.

Toll/IL-1 receptor domain-containing adaptor inducing IFN-β (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct …

Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-β promoter in the Toll-like receptor signaling

Shp-2 Phosphatase Negatively Regulates The Trif Adaptor Protein-Dependent Type I Interferon And Proinflammatory Cytokine Production

Toll like receptor 3 mediated activation of NF κB and IRF3 diverges at Toll IL 1 receptor domain containing adapter inducing IFN β

Toll-like Receptor 3-Mediated Activation of NF-κB and IRF3 Diverges at Toll-IL-1 Receptor Domain-Containing Adapter Inducing IFN-β

Mechanisms of the TRIF-induced Interferon-stimulated Response Element and NF-κB Activation and Apoptosis Pathways

Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway

Akt Contributes to Activation of the TRIF-Dependent Signaling Pathways of TLRs by Interacting with TANK-Binding Kinase 1

TNF Receptor-Associated Factor-1 (TRAF1) Negatively Regulates Toll/IL-1 Receptor Domain-Containing Adaptor Inducing IFN-beta (Trif)-Mediated Signaling.

Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR) 7-and TLR9-mediated interferon-α induction

Analysis of a TIR-less Splice Variant of TRIF Reveals an Unexpected Mechanism of TLR3-mediated Signaling

TRAM is specifically involved in the Toll-like receptor 4–mediated MyD88-independent signaling pathway

The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes.

TIFAB regulates the TIFA-TRAF6 signaling pathway involved in innate immunity by forming a heterodimer complex with TIFA

Tbk1, A Central Kinase In Innate Immune Sensing Of Nucleic Acids And Beyond

Recruitment of TLR adapter TRIF to TLR4 signaling complex is mediated by the second helical region of TRIF TIR domain

The Tumor Necrosis Factor Receptor 2 Signal Transducers TRAF2 and C-Iap1 Are Components of the Tumor Necrosis Factor Receptor 1 Signaling Complex

TRAF6-dependent Act1 phosphorylation by the IκB kinase-related kinases suppresses interleukin-17-induced NF-κB activation.

Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4

LPS-TLR4 Signaling to IRF-3/7 and NF-κB Involves the Toll Adapters TRAM and TRIF

Tumor Necrosis Factor Receptor-Associated Factor Regulation of Nuclear Factor κB and Mitogen-Activated Protein Kinase Pathways